Decreased Plasma Brain-Derived Neurotrophic Factor and Vascular Endothelial Growth Factor Concentrations during Military Training

Decreased concentrations of plasma brain-derived neurotrophic factor (BDNF) and serum BDNF have been proposed to be a state marker of depression and a biological indicator of loaded psychosocial stress. Stress evaluations of participants in military mission are critically important and appropriate objective biological parameters that evaluate stress are needed. In military circumstances, there are several problems to adopt plasma BDNF concentration as a stress biomarker. First, in addition to psychosocial stress, military missions inevitably involve physical exercise that increases plasma BDNF concentrations. Second, most participants in the mission do not have adequate quality or quantity of sleep, and sleep deprivation has also been reported to increase plasma BDNF concentration. We evaluated plasma BDNF concentrations in 52 participants on a 9-week military mission. The present study revealed that plasma BDNF concentration significantly decreased despite elevated serum enzymes that escaped from muscle and decreased quantity and quality of sleep, as detected by a wearable watch-type sensor. In addition, we observed a significant decrease in plasma vascular endothelial growth factor (VEGF) during the mission. VEGF is also neurotrophic and its expression in the brain has been reported to be up-regulated by antidepressive treatments and down-regulated by stress. This is the first report of decreased plasma VEGF concentrations by stress. We conclude that decreased plasma concentrations of neurotrophins can be candidates for mental stress indicators in actual stressful environments that include physical exercise and limited sleep.

[1]  H. Lang,et al.  Creatine kinase, an enzyme of many forms. , 1982, Clinical chemistry.

[2]  R. Duman,et al.  VEGF as a potential target for therapeutic intervention in depression. , 2008, Current opinion in pharmacology.

[3]  S. Soekadar,et al.  Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. , 2007, The Journal of clinical psychiatry.

[4]  奥野 香苗.  Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan , 2011 .

[5]  R. Kvetňanský,et al.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  R. Aitken.  Measurement of feelings using visual analogue scales. , 1969, Proceedings of the Royal Society of Medicine.

[7]  Changsu Han,et al.  Low plasma BDNF is associated with suicidal behavior in major depression , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  M. Sasvári-Székely,et al.  Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study. , 2013, Journal of affective disorders.

[9]  F. Sun,et al.  Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor , 2005, Journal of neuroscience research.

[10]  Glen E Duncan,et al.  Effects of aerobic exercise on mild cognitive impairment: a controlled trial. , 2010, Archives of neurology.

[11]  M. Shichiri,et al.  Relationship between autonomic nervous system activity during sleep and fasting glucose in Japanese workers. , 2011, Industrial health.

[12]  O. Çalıyurt,et al.  Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression , 2009, Brain Research Bulletin.

[13]  R T Schimke,et al.  Control of enzyme levels in mammalian tissues. , 2006, Advances in enzymology and related areas of molecular biology.

[14]  C. Cotman,et al.  Exercise and brain neurotrophins , 1995, Nature.

[15]  N. Gervasoni,et al.  Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity , 2005, Biological Psychiatry.

[16]  M. Banasr,et al.  Vascular Endothelial Growth Factor Signaling is Required for the Behavioral Actions of Antidepressant Treatment: Pharmacological and Cellular Characterization , 2009, Neuropsychopharmacology.

[17]  Z. Makkos,et al.  Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression. , 2012, Journal of affective disorders.

[18]  M. Joëls,et al.  Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk‐1 protein expression , 2005, The European journal of neuroscience.

[19]  William A Banks,et al.  Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.

[20]  H. Nasrallah,et al.  Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. , 2010, The international journal of neuropsychopharmacology.

[21]  J. Zoladz,et al.  Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[22]  R. Yoshimura,et al.  Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan , 2011, Psychiatry Research.

[23]  B. Penninx,et al.  The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met , 2010, Psychopharmacology.

[24]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  S Akselrod,et al.  Fluctuations in autonomic nervous activity during sleep displayed by power spectrum analysis of heart rate variability , 1995, Neurology.

[26]  J. Virchow,et al.  The impact of age, weight and gender on BDNF levels in human platelets and plasma , 2004, Neurobiology of Aging.

[27]  H. Kunugi,et al.  Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders , 2010, Journal of Neural Transmission.

[28]  R. Duman,et al.  Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors , 2003, The Journal of Neuroscience.

[29]  A. Placentino,et al.  VEGF serum levels in depressed patients during SSRI antidepressant treatment , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  Takuji Suzuki,et al.  Development of a Sleep Monitoring System with Wearable Vital Sensor for Home Use , 2009, BIODEVICES.

[31]  A. Sadeh,et al.  Activity-based sleep-wake identification: an empirical test of methodological issues. , 1994, Sleep.

[32]  R. Yoshimura,et al.  Two cases of burning mouth syndrome treated with olanzapine , 2008, Psychiatry and clinical neurosciences.

[33]  S. Hsieh,et al.  Effects of a 7-day eccentric training period on muscle damage and inflammation. , 2001, Medicine and science in sports and exercise.

[34]  G. Özkaya,et al.  Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features , 2012, Therapeutic advances in psychopharmacology.

[35]  R. Duman,et al.  VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants , 2007, Proceedings of the National Academy of Sciences.

[36]  M. Amore,et al.  VEGF plasma level variations in duloxetine-treated patients with major depression. , 2013, Journal of affective disorders.

[37]  D. Luckenbaugh,et al.  Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): A pilot study , 2011, Brain Research Bulletin.

[38]  D. J. Mullaney,et al.  Automatic sleep/wake identification from wrist activity. , 1992, Sleep.

[39]  D. Helmeste,et al.  Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects , 2008, Neuroscience Letters.

[40]  J. Aubry,et al.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients , 2002, Psychiatry Research.

[41]  Sun-Hwa Park,et al.  Decreased plasma BDNF level in depressive patients. , 2007, Journal of affective disorders.